Main news

ADT for Prostate Cancer: What's the Risk on the Heart?
ADT for Prostate Cancer: What's the Risk on the Heart? Androgen deprivation therapy (ADT) for localized prostate cancer increases the risk of myocardial infarction (MI), stroke, and other cardiovascular disease (CVD) events as well as death, according to a study from Norway.


Genetic Test for Six Chronic Diseases Undergoing Clinical Trial
Genetic Test for Six Chronic Diseases Undergoing Clinical Trial A new type of genetic test known as a polygenic risk score could change the way clinicians detect and treat chronic illnesses. But to be widely used, genomic findings in large populations first need to be translated into valid clinical tests for individual patients. Then physicians need meaningful interpretations of test data to help make clinical decisions about patient care.


Greater Triglyceride-Glucose Index Variability Tied to CV Risk
Greater Triglyceride-Glucose Index Variability Tied to CV Risk The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed.


Smokers With Heart Disease Could Gain 5 Years by Quitting
Smokers With Heart Disease Could Gain 5 Years by Quitting Smoking cessation appears to be comparable to the use of three targeted drugs in warding off future major cardiovascular events in smokers with atherosclerotic cardiovascular disease (ASCVD), according to a new study.


FDA Approves Fitbit's AFib-Detection Software
FDA Approves Fitbit's AFib-Detection Software A popular fitness tracker company has received approval from the Food and Drug Administration for a new software algorithm to detect atrial fibrillation (AFib), Fitbit announced on April 11.


The Uphill Struggle for High-Intensity Statins in ASCVD Patients
The Uphill Struggle for High-Intensity Statins in ASCVD Patients New research suggests physicians face a Herculean task to get Americans with atherosclerotic cardiovascular disease (ASCVD) to take high-intensity statins, despite multiple professional guidelines giving the therapy their highest level recommendation.


Pfizer Recalls BP Drugs Because of Potential Carcinogen
Pfizer Recalls BP Drugs Because of Potential Carcinogen Pfizer is voluntarily recalling some antihypertensive medications because of unacceptable levels of a potential carcinogen, the company announced.


Left Atrial Dysfunction Linked to Future Dementia Risk
Left Atrial Dysfunction Linked to Future Dementia Risk A new study has suggested that left atrial dysfunction could be a risk factor for the future development of dementia, raising the possibility of a new approach to dementia prevention.


Calcium Scores Predict Sudden-Death Risk in Preclinical CAD in Large Cohort Study
Calcium Scores Predict Sudden-Death Risk in Preclinical CAD in Large Cohort Study Calcium indicators predict the risk of sudden death in preclinical coronary heart disease in a large cohort study


High Triglycerides Up CV Risk After Atherothrombotic Stroke
High Triglycerides Up CV Risk After Atherothrombotic Stroke Patients who have had a stroke or transient ischemic attack (TIA) of atherothrombotic origin and have high triglyceride levels are at increased risk of having further cardiovascular events, including a recurrent stroke, even if they are taking statins, a new study shows.


Ross Procedure Making a Comeback in Aortic Valve Disease
Ross Procedure Making a Comeback in Aortic Valve Disease The Ross procedure, which can be used to treat young people with severe aortic valve disease, has seen wide swings in popularity over the years, but now, with consistent data on long-term survival and valve durability, numbers are steadily climbing again.


AHA Advisory Endorses Endovascular Thrombectomy for Large Core Ischemic Stroke
AHA Advisory Endorses Endovascular Thrombectomy for Large Core Ischemic Stroke Results of six recent trials of endovascular thrombectomy (EVT) for patients with large-core ischemic stroke (LCIS) provide strong evidence for the benefit of this intervention compared with medical management (MM), a new Science Advisory from the American Heart Association (AHA) has concluded.


Editorial Activity

cardiology book

World Heart Day
World Heart Day On World Heart Day, 29 September 2020, we’re asking the world to Use Heart to beat CVD ... for your loved ones, society and you.



Major Indexing Service Calls Out Cardiology Journals for Self-Citation
Major Indexing Service Calls Out Cardiology Journals for Self-Citation More than 70% of the citations in one journal were to other papers in that journal. Another published a single paper that cited nearly 200 other articles in the journal.


Novel Lipid Therapies: 5 Things to Know
Novel Lipid Therapies: 5 Things to Know The development of novel pharmacotherapies targeting low-density lipoprotein (LDL), lipoprotein a, and triglycerides (TG) to help prevent patients' risk of atherosclerotic cardiovascular disease (ASCVD) has accelerated during the past decade.


COVID-19 and cardiovascular diseases: main aspects
COVID-19 and cardiovascular diseases: main aspects Igor S. Yavelov MD, PhD, Professor of cardiology


Administration of patients during and after a coronavirus pandemic. Interview with professor Mekhman N. Mamedov.
Administration of patients during and after a coronavirus pandemic. Interview with professor Mekhman N. Mamedov. Dear Colleagues! On April 27, 2021, at the initiative of the Indonesian Society of Cardiology, an online meeting was held with one of the leading experts of Russia in the cardiology, Professor Mekhman N Mamedov.


Hypertension Clinical Practice Guidelines (ISH, 2020)  International Society of Hypertension (ISH)
Hypertension Clinical Practice Guidelines (ISH, 2020) International Society of Hypertension (ISH) The International Society of Hypertension (ISH) released their global recommendations on the management of hypertension in adults aged 18 years and older in June 2020.


Social Isolation Tied to Higher Risk of CV Events, Death
Social Isolation Tied to Higher Risk of CV Events, Death Social isolation is associated with an increased risk of a cardiovascular event of more than 40%, and of all-cause mortality approaching 50%, new research suggests.